Want to see SE:PTRK full AI Analyst Report?

Physitrack Limited (PTRK) Price & Analysis

1 Followers

PTRK Stock Chart & Stats

kr8.06

kr0.26(3.23%)

At close: Jul 27 4:00 PM EDT

kr8.06

kr0.26(3.23%)

Day’s Range― - ―

52-Week Rangekr7.36 - kr16.35

Previous CloseN/A

Volume42.99K

Average Volume (3M)39.76K

Market Cap

kr188.62M

Enterprise Valuekr188.30M

Total Cash (Recent Filing)kr485.31K

Total Debt (Recent Filing)kr4.23M

Price to Earnings (P/E)―

Beta0.57

Next Earnings

Feb 26, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.48

Shares Outstanding16,260,765

10 Day Avg. Volume63,372

30 Day Avg. Volume39,764

Financial Highlights & Ratios

PEG Ratio-0.57

Price to Book (P/B)1.97

Price to Sales (P/S)1.42

P/FCF Ratio5.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.1

Revenue Forecast (FY)kr13.80M

Bulls Say, Bears Say

Bulls Say

Recurring Revenue ModelThe high recurring-revenue mix and strong gross margin provide a durable foundation for revenue visibility and operating leverage. ARR growth indicates ongoing customer value, while the software model can support cash generation and reinvestment as the platform scales.

Core Platform Growth And RetentionStrong growth in the established core platform, combined with low reported churn and higher revenue per license, suggests improving monetization without relying solely on new customers. This supports durable expansion potential and strengthens the economics of the existing installed base.

Product Expansion And EMR TractionThe new products broaden Physitrack’s role in rehabilitation workflows beyond exercise prescription. Early EMR adoption, including participation from existing and new customers, provides evidence of demand for a wider platform and creates a foundation for future subscription growth.

Bears Say

Persistent Net LossesVery large net losses weaken earnings quality and indicate that positive operating metrics have not yet translated into durable bottom-line profitability. Continued losses can erode the capital base, constrain financial flexibility, and make future growth more dependent on sustained operating improvement.

Elevated Investment CostsInvestment in North America, product engineering, launch marketing and customer support is keeping the cost base elevated while reducing near-term EBITDA and free cash flow. If revenue scaling lags these commitments, margin recovery and the medium-term profitability target could be delayed.

Wellness Customer And ARR PressureThe large-customer loss exposes pressure within the Wellness division and partially offsets growth in Lifecare. Lower segment ARR and near-flat revenue can weaken recurring growth, reduce scale benefits, and increase reliance on the core platform and newer products.

Physitrack Limited News

Physitrack Q3 Earnings Call Highlights Profitable Growth

Physitrack Limited (($SE:PTRK)) has held its Q3 earnings call. Read on for the main highlights of the call....

11d ago

PTRK

PTRK FAQ

What was Physitrack Limited’s price range in the past 12 months?

Physitrack Limited lowest stock price was kr7.36 and its highest was kr16.35 in the past 12 months.

What is Physitrack Limited’s market cap?

Physitrack Limited’s market cap is kr188.62M.

When is Physitrack Limited’s upcoming earnings report date?

Physitrack Limited’s upcoming earnings report date is Feb 26, 2027 which is in 117 days.

How were Physitrack Limited’s earnings last quarter?

Physitrack Limited released its earnings results on Oct 20, 2026. The company reported kr0.11 earnings per share for the quarter.

Is Physitrack Limited overvalued?

According to Wall Street analysts Physitrack Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Physitrack Limited pay dividends?

Physitrack Limited does not currently pay dividends.

What is Physitrack Limited’s EPS estimate?

Physitrack Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Physitrack Limited have?

Physitrack Limited has 16,260,765 shares outstanding.

What happened to Physitrack Limited’s price movement after its last earnings report?

Physitrack Limited reported an EPS of kr0.11 in its last earnings report. Following the earnings report the stock price went up 2.479%.

Which hedge fund is a major shareholder of Physitrack Limited?

Currently, no hedge funds are holding shares in SE:PTRK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Physitrack Limited

Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.